174 related articles for article (PubMed ID: 28753791)
21. Evidence and Clinical Relevance of Tumor Flare in Patients Who Discontinue Tyrosine Kinase Inhibitors for Treatment of Metastatic Renal Cell Carcinoma.
Iacovelli R; Massari F; Albiges L; Loriot Y; Massard C; Fizazi K; Escudier B
Eur Urol; 2015 Jul; 68(1):154-60. PubMed ID: 25466943
[TBL] [Abstract][Full Text] [Related]
22. Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
Kawaishi M; Fujiwara Y; Fukui T; Kato T; Yamada K; Ohe Y; Kunitoh H; Sekine I; Yamamoto N; Nokihara H; Watabe T; Shimoda Y; Arao T; Nishio K; Tamura T; Koizumi F
J Thorac Oncol; 2009 Feb; 4(2):208-13. PubMed ID: 19179898
[TBL] [Abstract][Full Text] [Related]
23. A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma.
Apolo AB; Karzai FH; Trepel JB; Alarcon S; Lee S; Lee MJ; Tomita Y; Cao L; Yu Y; Merino MJ; Madan RA; Parnes HL; Steinberg SM; Rodriguez BW; Seon BK; Gulley JL; Arlen PM; Dawson NA; Figg WD; Dahut WL
Clin Genitourin Cancer; 2017 Feb; 15(1):77-85. PubMed ID: 27328856
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
Goodale D; Phay C; Brown W; Gray-Statchuk L; Furlong P; Lock M; Chin-Yee I; Keeney M; Allan AL
Cytometry B Clin Cytom; 2009 Mar; 76(2):107-17. PubMed ID: 18727054
[TBL] [Abstract][Full Text] [Related]
25. Microfluidic assay of circulating endothelial cells in coronary artery disease patients with angina pectoris.
Chen S; Sun Y; Neoh KH; Chen A; Li W; Yang X; Han RPS
PLoS One; 2017; 12(7):e0181249. PubMed ID: 28704506
[TBL] [Abstract][Full Text] [Related]
26. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
Go RS; Jobe DA; Asp KE; Callister SM; Mathiason MA; Meyer LA; Bottner WA; Cole CE; Farnen JP; Frisby KA
Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423
[TBL] [Abstract][Full Text] [Related]
27. Isolation of a circulating CD45-, CD34dim cell population and validation of their endothelial phenotype.
Tropea MM; Harper BJ; Graninger GM; Phillips TM; Ferreyra G; Mostowski HS; Danner RL; Suffredini AF; Solomon MA
Thromb Haemost; 2014 Oct; 112(4):770-80. PubMed ID: 25057108
[TBL] [Abstract][Full Text] [Related]
28. Can determination of circulating endothelial cells and serum caspase-cleaved CK18 predict for response and survival in patients with advanced non-small-cell lung cancer receiving endostatin and paclitaxel-carboplatin chemotherapy? a retrospective study.
Chu TQ; Ding H; Garfield DH; Gu AQ; Pei J; Du WD; Han BH
J Thorac Oncol; 2012 Dec; 7(12):1781-1789. PubMed ID: 23154549
[TBL] [Abstract][Full Text] [Related]
29. A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients.
Mancuso P; Calleri A; Gregato G; Labanca V; Quarna J; Antoniotti P; Cuppini L; Finocchiaro G; Eoli M; Rosti V; Bertolini F
PLoS One; 2014; 9(12):e114713. PubMed ID: 25506915
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category.
Davis ID; Xie W; Pezaro C; Donskov F; Wells JC; Agarwal N; Srinivas S; Yuasa T; Beuselinck B; Wood LA; Ernst DS; Kanesvaran R; Knox JJ; Pantuck A; Saleem S; Alva A; Rini BI; Lee JL; Choueiri TK; Heng DYC
Eur Urol; 2017 Jun; 71(6):970-978. PubMed ID: 27771126
[TBL] [Abstract][Full Text] [Related]
31. Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome.
Ramcharan KS; Lip GY; Stonelake PS; Blann AD
Int J Colorectal Dis; 2015 Mar; 30(3):315-21. PubMed ID: 25598043
[TBL] [Abstract][Full Text] [Related]
32. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients.
Beerepoot LV; Mehra N; Vermaat JS; Zonnenberg BA; Gebbink MF; Voest EE
Ann Oncol; 2004 Jan; 15(1):139-45. PubMed ID: 14679134
[TBL] [Abstract][Full Text] [Related]
33. Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy.
Mancuso P; Colleoni M; Calleri A; Orlando L; Maisonneuve P; Pruneri G; Agliano A; Goldhirsch A; Shaked Y; Kerbel RS; Bertolini F
Blood; 2006 Jul; 108(2):452-9. PubMed ID: 16543470
[TBL] [Abstract][Full Text] [Related]
34. A new approach for rapid and reliable enumeration of circulating endothelial cells in patients.
Kraan J; Strijbos MH; Sieuwerts AM; Foekens JA; den Bakker MA; Verhoef C; Sleijfer S; Gratama JW
J Thromb Haemost; 2012 May; 10(5):931-9. PubMed ID: 22385979
[TBL] [Abstract][Full Text] [Related]
35. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R
Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917
[TBL] [Abstract][Full Text] [Related]
36. Circulating endothelial progenitors and CXCR4-positive circulating endothelial cells are predictive markers for bevacizumab.
Matsusaka S; Mishima Y; Suenaga M; Terui Y; Kuniyoshi R; Mizunuma N; Hatake K
Cancer; 2011 Sep; 117(17):4026-32. PubMed ID: 21858803
[TBL] [Abstract][Full Text] [Related]
37. Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.
Beije N; Kraan J; den Bakker MA; Maat APWM; van der Leest C; Cornelissen R; Van NM; Martens JWM; Aerts JGJV; Sleijfer S
Cell Oncol (Dordr); 2017 Oct; 40(5):511-519. PubMed ID: 28577209
[TBL] [Abstract][Full Text] [Related]
38. Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas.
Rowand JL; Martin G; Doyle GV; Miller MC; Pierce MS; Connelly MC; Rao C; Terstappen LW
Cytometry A; 2007 Feb; 71(2):105-13. PubMed ID: 17226859
[TBL] [Abstract][Full Text] [Related]
39. Circulating endothelial cells and stroke: influence of stroke subtypes and changes during the course of disease.
Woywodt A; Gerdes S; Ahl B; Erdbruegger U; Haubitz M; Weissenborn K
J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):452-8. PubMed ID: 21852153
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancer.
Massard C; Borget I; Le Deley MC; Taylor M; Gomez-Roca C; Soria JC; Farace F
Eur J Cancer; 2012 Jun; 48(9):1354-62. PubMed ID: 22370181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
